Drug Patent Prosecution Timing: The Strategic Playbook for Maximizing Pharmaceutical Market Exclusivity
The 20-year patent term is the most cited number in pharmaceutical business strategy. It is also, in practice, a fiction. […]
Pharma Patent Expiration Calendar: The Complete LOE Strategy Guide
Part I: The Exclusivity Architecture: What Executives Get Wrong About the 20-Year Rule The number ’20 years’ is the most
Pharma Patent Expiration Calendar: The Complete LOE Strategy Guide Read Post »
Patent Cliff Playbook: How Generic Firms Win $200B in Off-Patent Drug Markets
Why This Cliff Is Different Generic and biosimilar drugs saved the U.S. healthcare system an estimated $3.1 trillion over the
Patent Cliff Playbook: How Generic Firms Win $200B in Off-Patent Drug Markets Read Post »
Process Analytical Technology for Generics: The Manufacturing Edge That Builds IP and Kills Commoditization
The generic pharmaceutical industry has spent thirty years perfecting a business model that no longer works. The playbook was elegant
How Governments Control the Generic Drug Market in India, China, Brazil, and South Africa
A deep-dive strategic guide for pharma IP teams, portfolio managers, R&D leads, and institutional investors on the regulatory, patent, and
Pharmaceutical Patent and Regulatory Exclusivity: The Complete Strategic Playbook for Managing Overlaps, Defending Franchises, and Timing Market Entry
Who this is for: IP teams at innovator and generic companies, portfolio managers running LOE models, R&D leads evaluating lifecycle
Reverse Engineer Your Way to Generic Drug Dominance: The Complete Deformulation Playbook
The Market You’re Actually Competing In The generic drug industry saves the U.S. healthcare system more than $445 billion per
Reverse Engineer Your Way to Generic Drug Dominance: The Complete Deformulation Playbook Read Post »
Pharmaceutical Preliminary Injunctions: The Legal Weapon That Wins Before Trial
Who This Guide Is For This is not an overview. It is a field manual for IP counsel preparing a
Pharmaceutical Preliminary Injunctions: The Legal Weapon That Wins Before Trial Read Post »
Drug Patents vs. PTAB: The Dual-Track Strategy Guide That Wins Market Exclusivity
Introduction: Two Systems Built for Different Problems, Forced to Coexist In pharmaceutical patent law, the rules changed permanently on September
Drug Patents vs. PTAB: The Dual-Track Strategy Guide That Wins Market Exclusivity Read Post »
